Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0001127602-16-060652

Options or other derivatives

  • President & CEO acquired 57,149 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Simon, Christopher President & CEO 2016-08-16 Grant or award · Performance Shares +57,149 $35.00 $1,999,981 57,149 D
Loading xslF345X03/form4.xml…